We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Researcher Endangers Patient in Phase III Trial
FDA: Researcher Endangers Patient in Phase III Trial
March 4, 2009
A clinical investigator failed to report an adverse event in a drug clinical trial and kept the patient in the study, endangering her safety, according to an FDA warning letter.